Publication Name	World Journal of Gastroenterology
Manuscript ID	26091
Country	Australia

Received	2016-03-29 08:44
Peer-Review Started	2016-04-01 08:50
To Make the First Decision	2016-05-30 09:21
Return for Revision	2016-05-30 13:10
Revised	2016-07-06 12:21
Second Decision	2016-07-27 19:30
Accepted by Journal Editor-in-Chief	2016-07-30 14:13
Accepted by Company Editor-in-Chief	2016-08-05 17:44
Articles in Press	2016-08-05 17:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-09-09 11:49
Publish the Manuscript Online	2016-09-26 08:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Iron and non-alcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Laurence J Britton, V Nathan Subramaniam and Darrell HG Crawford
Funding Agency and Grant Number
Corresponding Author	Dr. Laurence J Britton, Gallipoli Medical Research Institute, The University of Queensland, Greenslopes Private Hospital, Newdegate Street, Greenslopes, Brisbane, Queensland 4120, Australia. l.britton@uq.edu.au
Key Words	Iron; Fatty liver; Liver steatosis; Insulin resistance; Steatohepatitis; Diabetes mellitus; Adipose tissue
Core Tip	Iron represents a potential therapeutic target for the treatment of non-alcoholic fatty liver disease (NAFLD). There are extensive data that link iron and disease pathogenesis in human studies as well as animal and cell culture models. Studies have predominantly focussed on the role of hepatic iron, although recently adipose tissue has emerged as a site at which iron may promote insulin resistance. In this review, we summarize the human and basic science data that have evaluated the role of iron in NAFLD pathogenesis.
Publish Date	2016-09-26 08:04
Citation	Britton LJ, Subramaniam VN, Crawford DHG. Iron and non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(36): 8112-8122
URL	http://www.wjgnet.com/1007-9327/full/v22/i36/8112.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i36.8112

Full Article (PDF)	WJG-22-8112.pdf
Full Article (Word)	WJG-22-8112.doc
Manuscript File	26091-Review.docx
Answering Reviewers	26091-Answering reviewers.pdf
Audio Core Tip	26091-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26091-Conflict-of-interest statement.pdf
Copyright License Agreement	26091-Copyright assignment.pdf
Peer-review Report	26091-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26091-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26091-Scientific misconduct check.pdf
Scientific Editor Work List	26091-Scientific editor work list.pdf